v3.23.2
Fair Value of Financial Instruments - Narrative (Details)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability $ 760,000 $ 1,820,000
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets measured at fair value on recurring basis $ 0 $ 0
Level 3 | Measurement Input, Clinical Development Success | Valuation Technique, Scenario-Based And Discounted Cash Flow    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability, measurement input 0 0
Level 3 | Other than Derivative Liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities measured at fair value on recurring basis $ 0 $ 0
Collateral Agent, Pharmakon    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability $ 800,000 $ 1,800,000